Biofrontera

AMELUZ

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Biofrontera

Ameluz HCPCS:

J7345

HCPCS Code Descriptor:

Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg

Category:

J Code

Ameluz NDCs:

70621-0101-10, 70621-0101-01, 70621-0101-20

Primary Type:

Oncology Dermatology

Generic/Specialty Status:

Single-Source

Package Type:

Tube

Route of Administration:

Topical application

Ameluz CPT Codes:

Potential CPT administration codes for Ameluz can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70621-0101-20

About Ameluz:

AMELUZ is an Oncology Dermatology drug manufactured by Biofrontera and administered via the Topical application route of administration. The J Code: J7345 is aligned to the drug AMELUZ.

ACCESS PRICING AND MORE BY REGISTERING

J7345 Added Date:

January 1, 2018

J7345 Effective Date:

January 1, 2018

J7345 Termination Date:

HCPCS Active

Ameluz billing and coding information can be found through Biofrontera at the link below:
Our team did not identify a source for Ameluz patient assistance information. Please reach out to our team if you feel that this is a mistake.
AMELUZ prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for AMELUZ. Please check back in a few weeks.